充分利用补充生物标志物用于精确的癌症护理.
Houcine Hamidi1, Idris Boudhabhay2, Marie-Agnes Dragon-Durey1
1Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université Paris Cité, Inflammation, Complement and Cancer team, Paris, France; Laboratoire d'Immunologie, Hôpital Européen Georges Pompidou, APHP, Paris, France; University Hospital Federation (FHU) COMET, Paris, France.
Seminars in immunology
|May 16, 2025
概括
补体系统是瘤微环境中的关键参与者,显示出作为癌症生物标志物的潜力. 研究强调其在瘤发育,预后和早期检测和治疗监测的潜力中的作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 瘤微环境 (TME) 显著影响癌症进展和治疗结果.
- 补充系统,一种蛋白质级联,在TME中起着关键作用.
- 了解补体在癌症中的功能对于开发新的诊断和治疗策略至关重要.
研究的目的:
- 审查当前关于补充系统作为癌症生物标志物潜力的数据.
- 探索补充系统分析如何有助于癌症检测,分期和治疗监测.
- 确定补充系统在综合癌症管理中的演变作用.
主要方法:
- 转录组分析以基于补充基因表达和预后影响来分类瘤.
- 免疫覆盖可视化补充蛋白和碎片表达以及瘤和TME中的沉积.
- 在体液 (如血液) 中分析补体激活片段和自身抗体,用于非侵入性生物标志物识别.
主要成果:
- 补充基因表达模式与瘤预后相关.
- 补充蛋白和碎片在瘤和TME中得到表达和沉积.
- 循环补体激活片段和自身抗体作为特定癌症类型的非侵入性生物标志物.
结论:
- 补体系统是瘤学中一个有前途的生物标志物,为瘤生物学和患者预后提供了洞察力.
- 基于补充的生物标志物可以促进非侵入性癌症检测,分期和潜在的治疗监测.
- 进一步研究和开发补充向疗法和分析工具对于将补充系统整合到临床癌症管理中至关重要.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.